Patient and donor characteristics (N = 35)
| Patient and disease characteristic . | Value . |
|---|---|
| Median age (range), y | 62 (20-74) |
| Sex, n (%) | |
| Male | 21 (60) |
| Female | 14 (40) |
| Diagnosis, n(%) | |
| Mycosis fungoides | 13 (37) |
| Stage IIB* | 7 (20) |
| Stage IVA | 6 (17) |
| Large cell transformation | 12 (34) |
| Skin only | 8 (23) |
| Skin plus extracutaneous site | 4 (11) |
| Sézary syndrome | 22 (63) |
| Stage IVA | 17 (49) |
| IVB | 5 (14) |
| Large cell transformation | 8 (23) |
| Skin only | 3 (9) |
| Extracutaneous site only | 3 (9) |
| Skin plus extracutaneous site | 2 (5) |
| Retro-CLIPI, n (%)† | |
| High risk | 18 (52) |
| Intermediate risk | 13 (37) |
| Low risk | 4 (11) |
| Time from diagnosis to allogeneic HCT, median (range), mo | 40 (9-152) |
| <24, n (%) | 12 (34) |
| ≥24, n (%) | 23 (66) |
| No. of previous systemic therapies, median (range) | 5 (2-13) |
| Active disease at the time of conditioning, n (%) | |
| Skin | 35 (100) |
| Blood | 12 (34) |
| Lymph node | 22 (63) |
| Visceral‡ | 5 (14) |
| Donor, n (%) | |
| Sibling | 13 (37) |
| Unrelated | 22 (63) |
| Matched | 15 (43) |
| Mismatched§ | 7 (20) |
| Donor–recipient CMV status, n (%) | |
| Donor and/or recipient seropositive | 27 (77) |
| Donor and recipient seronegative | 8 (23) |
| Patient and disease characteristic . | Value . |
|---|---|
| Median age (range), y | 62 (20-74) |
| Sex, n (%) | |
| Male | 21 (60) |
| Female | 14 (40) |
| Diagnosis, n(%) | |
| Mycosis fungoides | 13 (37) |
| Stage IIB* | 7 (20) |
| Stage IVA | 6 (17) |
| Large cell transformation | 12 (34) |
| Skin only | 8 (23) |
| Skin plus extracutaneous site | 4 (11) |
| Sézary syndrome | 22 (63) |
| Stage IVA | 17 (49) |
| IVB | 5 (14) |
| Large cell transformation | 8 (23) |
| Skin only | 3 (9) |
| Extracutaneous site only | 3 (9) |
| Skin plus extracutaneous site | 2 (5) |
| Retro-CLIPI, n (%)† | |
| High risk | 18 (52) |
| Intermediate risk | 13 (37) |
| Low risk | 4 (11) |
| Time from diagnosis to allogeneic HCT, median (range), mo | 40 (9-152) |
| <24, n (%) | 12 (34) |
| ≥24, n (%) | 23 (66) |
| No. of previous systemic therapies, median (range) | 5 (2-13) |
| Active disease at the time of conditioning, n (%) | |
| Skin | 35 (100) |
| Blood | 12 (34) |
| Lymph node | 22 (63) |
| Visceral‡ | 5 (14) |
| Donor, n (%) | |
| Sibling | 13 (37) |
| Unrelated | 22 (63) |
| Matched | 15 (43) |
| Mismatched§ | 7 (20) |
| Donor–recipient CMV status, n (%) | |
| Donor and/or recipient seropositive | 27 (77) |
| Donor and recipient seronegative | 8 (23) |